How Akasa Can Prevent Late-Stage Slippage and Build a Defendable Forecast
A RevIntel diagnostic designed for healthcare AI sales motions where clinical validation, security/compliance, and procurement determine deal velocity.
Optional execution sprint available.
Intelligence at Your Fingertips
RevIntel transforms millions of data points into actionable insights through our advanced AI-powered platform.
Commercial Brain
Neural network analyzing your pipeline in real-time
Data Flow
Watch your deals flow through the conversion funnel
Executive View
All your metrics in one unified command center
Akasa operates a complex sales motion with multiple products, regions, and buyer personas. Forecasting becomes challenging when deal reality spans many stakeholders, extended sales cycles, and varying CRM discipline across teams.
In enterprise deals, opportunities often stall in technical validation, security/compliance, commercial/legal, or procurement. Activity stays high, but CRM fields and deal notes frequently fail to reflect true next steps, decision process clarity, and stakeholder depth.
The outcome is predictable: late-stage deals remain 'active' without evidence, forecast becomes a negotiation, and leadership loses time reconciling conflicting views. RevIntel creates a consistent, evidence-based view of pipeline health and execution.
The Pipeline Challenge at Akasa
CRM Pattern
A pipeline with many large opportunities sitting 60–180+ days in Proposal/Commercial or Legal/Procurement, with frequent activity logged but incomplete next-step commitments, inconsistent close-date discipline, and weak stakeholder mapping.
CRM Reality
Many opportunities are stalled due to execution gaps: unclear decision process, missing mutual action plans, shifting scope, procurement delays, or misaligned internal ownership. Deals remain staged as 'active' to protect forecast while true close probability decreases.
What RevIntel Does
AI Chat on Pipeline Reality
Ask leadership questions in plain English and get answers grounded in CRM context: what's real, what's stuck, and what needs action this week.
Weekly Reports + Actions
Generate structured weekly pipeline reports that surface risks, bottlenecks, and next-best actions across practices and regions.
Deal Deep-Dive (Per Opportunity)
Analyze a single strategic deal: stakeholder map, decision process gaps, risk signals, and a focused action plan to accelerate or disqualify.
What RevIntel Would Detect
Illustrative example output based on common enterprise CRM patterns. Replace with live CRM data during the diagnostic.
Executive Summary
Akasa's healthcare AI pipeline shows strong product-market fit with $4.2M total value across 28 opportunities in revenue cycle management. However, forecast reliability is challenged by extended clinical validation cycles (60-120 days), inconsistent security/compliance stakeholder engagement, and weak tracking of pilot success metrics. Win rate of 20% is below healthcare SaaS benchmarks (28-35%), and top 8 deals represent 55% of pipeline, creating concentration risk. Immediate priorities: establish clinical validation framework with clear success criteria, mandate security/compliance stakeholder identification in discovery, and implement 45-day pilot rescue protocol.
Key Insights
- Strong healthcare RCM product-market fit with measurable ROI (denial reduction, A/R acceleration) creates compelling value proposition.
- Clinical validation phase lacks structured success criteria and timeline governance, leading to extended cycles.
- Security/compliance requirements surface late in sales cycle, causing unexpected delays and forecast slippage.
Ready to Fix Your Forecast?
Book a 15-minute diagnostic call and we'll show you exactly where your pipeline is breaking down.
Book Your Diagnostic Now